by Site Admin | Apr 7, 2022 | Featured, Lung
Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World Book Appointment March 16, 2022 – Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and...
by Site Dev | Oct 26, 2021 | Clinical Trials, Prostate
Prostate Cancer Clinical Trials Contact Us 1) First Line Metastatic mCRPC: USO #19191: BMS CA209-7DX: A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer...
by Site Dev | Oct 26, 2021 | Clinical Trials, Multiple Myeloma
Multiple Myeloma Clinical Trials Contact Us 1)Relapsed/Refractory MM/ IONA: A prospective, non-interventional, multinational, observational study with Isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM) Send UsA Message LOCATION*...
by Site Dev | Oct 26, 2021 | Clinical Trials, Colorectal
Colorectal CancerClinical Trials Contact Us 1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C...
by Site Dev | Oct 22, 2021 | Breast, Clinical Trials
Breast CancerClinical Trials Contact Us 1) Up to 3 lines of post-adjuvant or neoadjuvant therapy for TNBC/AYALA: AL-TNBC-01: A Phase 2, Multicenter, Open-label study of AL101 Monotherapy in Patients with Notch Activated Recurrent or Metastatic Triple Negative Breast...
by Site Dev | Oct 20, 2021 | Clinical Trials, Lymphoma
Lymphoma Clinical Trials Contact Us DIFFUSE LARGE B-CELL LYMPHOMA: (4) 1) 2ND line or greater/ SGN35-031: A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination with Lenalidomide...